Effect of γ-hydroxybutyrate in two rat models of focal cerebral damage

Brain Research

Volumn 986, Issue 1-2, 2003, Pages 181-190

  Ottani, Alessandra ^a   Saltini, Sabrina ^a   Bartiromo, Marta ^b   Zaffe, Davide ^a   Botticelli, Annibale Renzo ^c   Ferrari, Anna ^a   Bertolini, Alfio ^a   Genedani, Susanna ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Cerebral excitotoxicity; Cerebral ischemia; Circling behavior; Endothelin 1; Immunohistochemistry; Kainic acid; Sensory motor test; Spatial learning; Hydroxybutyrate

Indexed keywords

4 HYDROXYBUTYRIC ACID; ENDOTHELIN 1; KAINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; CORPUS STRIATUM; EVALUATION; GENERAL ANESTHESIA; LEARNING; MALE; MEMORY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; RAT; SENSORIMOTOR CORTEX;

EID: 0142090461     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)03252-9     Document Type: Article

References (52)

1. Anderson J.M., Lowe J. Histometry and image analysis. Bancroft J.D., Stevens A. Theory and Practice of Histological Techniques. 1990;597-618 Churchill Livingstone, Edinburgh, UK.
2. Artru A., Steen P., Michenfelder J. Gamma-hydroxybutyrate: cerebral, metabolic, vascular and protective effects. J. Neurochem. 35:1980;1114-1119.
3. Backman L., Ginovart N., Dixon R.A., Wahlin T.B., Wahlin A., Halldin C., Farde L. Age-related cognitive deficits mediated by changes in the striatal dopamine system. Am. J. Psychiatry. 157:2000;635-637.
4. Basile A.M., Nencini P., Inzitari D. Meccanismi molecolari dell'ischemia cerebrale: possibili interventi terapeutici. Ann. Ital. Med. Int. 14:1999;94-105.
5. Behl C., Hovey L., Krajewsky S., Schubert D., Reed J.C. BCL-2 prevents killing of neuronal cells by glutamate but not by amyloid beta protein. Biochem. Biophys. Res. Commun. 197:1993;949-956.
6. Ben-Ari Y., Tremblay E., Riche D., Ghilini G., Naquet R. Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neuroscience. 6:1981;1361-1391.
7. Bernasconi R., Mathivet P., Bischoff S., Marescaux C. Gamma-hydroxybutyric acid: an endogenous neuromodulator with abuse potential? Trends Pharm. Sci. 20:1999;135-141.
8. Bjorklund A., Dunnett S.B., Stenevi U., Lewis M.E., Iversen S.D. Reinnervation of the denervate striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensory-motor testing. Brain Res. 199:1980;307-333.
9. Boyd A.J., Sherman I.A., Saibil F.G., Mamelak M. The protective effect of γ-hydroxybutyrate in regional intestinal ischemia in the hamster. Gastroenterology. 99:1990;860-862.
10. Bralet J., Beley P., Bralet A.M., Beliz A. Influence of various agents on the development of brain edema in rat following microembolism. Stroke. 10:1979;653-656.
11. Csillag A. Striato-telencephalic and striato-tegmental circuits: relevance to learning in domestic chicks. Behav. Brain Res. 98:1999;227-236.
12. Dosmugambetova R.S. Prevention of stress-related disorders in the contractile function of non-ischemic areas of the heart during myocardial infarction using gamma-hydroxybutyric acid. Bull. Esp. Biol. Med. 96:1983;28-30.
13. B receptors. Neurosci. Lett. 216:1996;121-124.
14. Escuret E., Roquefeuil B., Frerebean P., Baldy-Moulinier M. Effect of hyperventilation associated with administration of central nervous depressant in brain injuries. Acta Neurol. Scand. 56:1977;154-155.
15. Ferrara S.D., Zotti S., Tedeschi L., Frison G., Castagna F., Gallimberti L., Gessa G.L., Palatini P. Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. Br. J. Clin. Pharmacol. 34:1992;231-235.
16. Floresco S.B., Braaksma D.N., Phillips A.G. Thalamic-cortical-striatal circuitry subserves working memory during delayed responding on a radial arm maze. J. Neurosci. 19:1999;11061-11071.
17. Fuxe K., Kurosawa N., Cintra A., Hallstrom A., Goiny M., Rosen L., Agnati L.F., Ungerstedt U. Involvement of local ischemia in endothelin-1 induced lesions on the neostriatum of the anaesthetized rat. Exp. Brain Res. 88:1992;131-139.
18. Godbout S.R., Jelenic P., Labrie C., Schmitt M., Bourguignon J.J. Effect of gamma-hydroxybutyrate and its antagonist NCS-382 on spontaneous cell firing in the prefrontal cortex of the rat. Brain Res. 673:1995;157-160.
19. Godin Y., Mark J., Mandel P. The effects of 4-hydroxybutyric acid on the biosynthesis of amino acid in the central nervous system. J. Neurochem. 15:1968;1085-1091.
20. Gratacos E., Rerez-Navarro E., Tolosa E., Arenas E., Alberch J. Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members. J. Neurochem. 78:2001;1287-1296.
21. 3H]hydroxybutyrate binding site as determined by quantitative autoradiography. J. Neurochem. 49:1987;1025-1032.
22. Kaufman E.E., Porrino L.J., Nelson T. Pyretic action of low doses of gamma-hydroxybutyrate in rats. Biochem. Pharmacol. 40:1990;2637-2640.
23. Lavyne M., Hariri R., Tankosic T., Babiak T. Effect of low dose γ-butyrolactone therapy on forebrain neuronal ischemia in unrestrained, awake rat. Neurosurgery. 12:1983;430-434.
24. Lehmann O., Jeltsch H., Lehnardt O., Pain L., Lazarus C., Cassel J.C. Combined lesions of cholinergic and serotonergic neurons in the rat brain using 192 IgG-saporin and 5,7-dihydroxytryptamine: neurochemical and behavioural characterization. Eur. J. Neurosci. 12:2000;67-79.
25. Macmillan V. The effects of gamma-hydroxybutyrate and gamma-butyrolactone upon the energy metabolism of the normoxic and hypoxic rat brain. Brain Res. 146:1978;177-187.
26. Maitre M. The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog. Neurobiol. 51:1997;337-361.
27. Maitre M., Rumigny J.F., Cash C.D., Mandel P. Subcellular distribution of γ-hydroxybutyrate binding sites in rat brain. Principal localization in the synaptosomal fraction. Biochem. Biophys. Res. Commun. 110:1983;262-265.
28. Marshall F., Teitelbaum P. Further analysis of sensory inattention following lateral hypothalamic damage in rats. J. Comp. Physiol. Psychol. 86:1974;375-395.
29. Mcnamara J.R.K., Skelton R.W. The neuropharmacological and neurochemical basis of place learning in the Morris water maze. Brain Res. Rev. 18:1993;33-49.
30. Morris R.G.M. Development of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods. 11:1984;47-60.
31. Muller U., Wachter T., Barthel H., Reuter M., Von Cramon D.Y. Striatal [123I]beta-CIT SPECT and prefrontal cognitive functions in Parkinson's disease. J. Neural Transm. 107:2000;303-319.
32. Olianas M.C., De Montis G.M., Mulas G., Tagliamonte A. The striatal dopaminergic function is mediated by the inhibition of a nigral non-dopaminergic neuronal system via a strio-nigral GABAergic pathway. Eur. J. Pharmacol. 49:1978;233-241.
33. Paxinos G., Watson G. The Rat Brain in Stereotaxic Coordinates. 1984;Academic Press, New York.
34. Pulsinelli W.A., Brierly J.B. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke. 10:1979;267-272.
35. Santamaria A., Ordaz-Moreno J., Rubio-Osornio M., Solis-Hernandez F., Rios C. Neuroprotective effect of dapsone against quinolate- and kainate-induced striatal neurotoxicity in rats. Pharmacol. Toxicol. 81:1997;271-275.
36. Sharkey J., Ritchie I.M., Kelly P.A.T. Perivascular microapplication of endothelin-1: a new model of focal cerebral ischaemia in the rat. J. Cereb. Blood Flow Metab. 13:1993;865-871.
37. Shu S.Y., Bao X., Li S., Niu D., Xu Z., Li Y. A new subdivision of mammalian neostriatum with functional implication to learning and memory. J. Neurosci. Res. 58:1999;242-253.
38. Shumate J.S., Snead O.C. Plasma and central nervous system kinetics of gamma-hydroxybutyrate. Res. Commun. Mol. Pathol. 25:1979;241-256.
39. Snead O.C. The gamma-hydroxybutyrate model of absence seizure: correlation of regional brain levels of gamma-hydroxybutyric acid and gamma-butyrolactone with spike and wave discharges. Neuropharmacology. 30:1991;161-167.
40. Snead O.C., Liu C.C. Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes. Biochem. Pharmacol. 16:1984;2587-2590.
41. Snead O.C., Yu R.K., Huttenlocher P.R. Gamma-hydroxybutyrate: correlation of serum and cerebrospinal fluid levels with electroencephalographic and behavioural effects. Neurology. 26:1976;51-56.
42. Stebbins G.T., Gabrielli J.D., Shannon K.M., Penn R.D., Goetz C.G. Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's disease. Brain Cogn. 42:2000;348-363.
43. Toga A.W., Santori E.M., Hazani R., Ambach K. A 3D digital map of rat brain. Brain Res. Bull. 38:1995;77-85.
44. Tunnicliff G. Significance of γ-hydroxybutyric acid in the brain. Gen. Pharmacol. 23:1992;1027-1034.
45. Van Ginneken C.A.M., Van Rossum J.M., Fleuren H.L.J.M. Linear and nonlinear kinetics of drug elimination. I. Kinetics on the basis of a single capacity-limited pathway of elimination with or without simultaneous supply-limited elimination. J. Parmacokinet. Biopharm. 2:1974;395-415.
46. Van Sassenbroeck D.K., De Paepe P., Belpaire F.M., Rosseel M.T., Martens P., Boon P.A., Buylaert W.A. Relationship between gamma-hydroxybutyrate plasma concentrations and its electroencephalographic effects in the rat. J. Pharm. Pharmacol. 53:2001;1687-1696.
47. Vayer P., Mandel P., Maitre M. Gamma-hydroxybutyrate, a possible neurotransmitter. Life Sci. 41:1987;1547-1557.
48. Vergoni A.V., Ottani A., Botticelli A.R., Zaffe D., Guano L., Loche A., Genedani S., Gessa G.L., Bertolini A. Neuroprotective effect of gamma-hydroxybutyrate in transient global cerebral ischemia in the rat. Eur. J. Pharmacol. 397:2000;75-84.
49. Wahlgren N.G. The Clomethiazole Acute Stroke Study (CLASS): safety results in 1356 patients with acute hemispheric stroke. Neurology. 50:1998;212.
50. Wolf D.S., Gearing M., Snowdon D.A., Mori H., Markesbery W.R., Mirra S.S. Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study. Alzheimer Dis. Assoc. Disord. 13:1999;226-231.
51. Wolfson L.I., Sakurada O., Sokoloff L. Effects of gamma butyrolactone on local cerebral glucose utilization in the rat. J. Neurochem. 29:1977;777-783.
52. B receptors. Eur. J. Pharmacol. 212:1992;291-294.